-
1
-
-
0035174896
-
Risk of prostate carcinoma death in patients with lymph node metastasis
-
Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001;91:66-73.
-
(2001)
Cancer
, vol.91
, pp. 66-73
-
-
Cheng, L.1
Zincke, H.2
Blute, M.L.3
Bergstralh, E.J.4
Scherer, B.5
Bostwick, D.G.6
-
2
-
-
5444246727
-
Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: Results of long-term followup
-
Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 2004;172:1860-4.
-
(2004)
J Urol
, vol.172
, pp. 1860-1864
-
-
Palapattu, G.S.1
Allaf, M.E.2
Trock, B.J.3
Epstein, J.I.4
Walsh, P.C.5
-
3
-
-
0037362992
-
Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
-
Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 2003;169:849-54.
-
(2003)
J Urol
, vol.169
, pp. 849-854
-
-
Bader, P.1
Burkhard, F.C.2
Markwalder, R.3
Studer, U.E.4
-
4
-
-
0036074546
-
Is a limited lymph node dissection an adequate staging procedure for prostate cancer?
-
discussion 18
-
Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002;168:514-8: discussion 18.
-
(2002)
J Urol
, vol.168
, pp. 514-518
-
-
Bader, P.1
Burkhard, F.C.2
Markwalder, R.3
Studer, U.E.4
-
5
-
-
0036129718
-
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis
-
Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002;167:1681-6.
-
(2002)
J Urol
, vol.167
, pp. 1681-1686
-
-
Heidenreich, A.1
Varga, Z.2
Von Knobloch, R.3
-
6
-
-
5444239738
-
Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer
-
Allaf ME, Palapattu GS, Track BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004;172:1840-4.
-
(2004)
J Urol
, vol.172
, pp. 1840-1844
-
-
Allaf, M.E.1
Palapattu, G.S.2
Track, B.J.3
Carter, H.B.4
Walsh, P.C.5
-
7
-
-
0017233631
-
Prostatic carcinoma: Incidence and location of unsuspected lymphatic metastases
-
McLaughlin AP, Saltzstein SL, McCullough DL, Gittes RF. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 1976;115:89-94.
-
(1976)
J Urol
, vol.115
, pp. 89-94
-
-
McLaughlin, A.P.1
Saltzstein, S.L.2
McCullough, D.L.3
Gittes, R.F.4
-
8
-
-
0030913315
-
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
-
Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997;277:1445-51.
-
(1997)
JAMA
, vol.277
, pp. 1445-1451
-
-
Partin, A.W.1
Kattan, M.W.2
Subong, E.N.3
-
9
-
-
0141988872
-
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer
-
Cagiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003;170:1798-803.
-
(2003)
J Urol
, vol.170
, pp. 1798-1803
-
-
Cagiannos, I.1
Karakiewicz, P.2
Eastham, J.A.3
-
10
-
-
0031016543
-
Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma
-
Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer 1997;79:528-37.
-
(1997)
Cancer
, vol.79
, pp. 528-537
-
-
Kattan, M.W.1
Stapleton, A.M.2
Wheeler, T.M.3
Scardino, P.T.4
-
11
-
-
0036837647
-
The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng/ml) in predicting prostate cancer: Is biopsy always required?
-
Gerstenbluth RE, Seftel AD, Hampel N, Oefelein MG, Resnick MI. The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng/ml) in predicting prostate cancer: is biopsy always required? J Urol 2002;168:1990-3.
-
(2002)
J Urol
, vol.168
, pp. 1990-1993
-
-
Gerstenbluth, R.E.1
Seftel, A.D.2
Hampel, N.3
Oefelein, M.G.4
Resnick, M.I.5
-
12
-
-
0035164411
-
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens
-
Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001;166:2295-6.
-
(2001)
J Urol
, vol.166
, pp. 2295-2296
-
-
Bochner, B.H.1
Herr, H.W.2
Reuter, V.E.3
-
13
-
-
15044341275
-
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era
-
DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 2005;173:1121-5.
-
(2005)
J Urol
, vol.173
, pp. 1121-1125
-
-
DiMarco, D.S.1
Zincke, H.2
Sebo, T.J.3
Slezak, J.4
Bergstralh, E.J.5
Blute, M.L.6
-
14
-
-
0037213515
-
Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer
-
discussion 47-8
-
Clark T, Parekh DJ, Cookson MS, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003;169:145-7: discussion 47-8.
-
(2003)
J Urol
, vol.169
, pp. 145-147
-
-
Clark, T.1
Parekh, D.J.2
Cookson, M.S.3
-
15
-
-
14144253895
-
Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?
-
Burkhard FC, Schumacher M, Thalmann GN, Studer UE. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? BJU Int 2005;95:275-8.
-
(2005)
BJU Int
, vol.95
, pp. 275-278
-
-
Burkhard, F.C.1
Schumacher, M.2
Thalmann, G.N.3
Studer, U.E.4
-
16
-
-
4444376712
-
Signaling to NF-κB
-
Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004;18:2195-224.
-
(2004)
Genes Dev
, vol.18
, pp. 2195-2224
-
-
Hayden, M.S.1
Ghosh, S.2
-
17
-
-
0036546501
-
NF-κB in cancer: From innocent bystander to major culprit
-
Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-10.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 301-310
-
-
Karin, M.1
Cao, Y.2
Greten, F.R.3
Li, Z.W.4
-
18
-
-
4544342570
-
Nuclear factor-κB: The enemy within
-
Aggarwal BB. Nuclear factor-κB: the enemy within. Cancer Cell 2004;6:203-8.
-
(2004)
Cancer Cell
, vol.6
, pp. 203-208
-
-
Aggarwal, B.B.1
-
19
-
-
3242798367
-
NF-κB activation in human prostate cancer: Important mediator or epiphenomenon?
-
Suh J, Rabson AB. NF-κB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem 2004;91:100-17.
-
(2004)
J Cell Biochem
, vol.91
, pp. 100-117
-
-
Suh, J.1
Rabson, A.B.2
-
20
-
-
0035849720
-
Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis
-
Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001;20:4188-97.
-
(2001)
Oncogene
, vol.20
, pp. 4188-4197
-
-
Huang, S.1
Pettaway, C.A.2
Uehara, H.3
Bucana, C.D.4
Fidler, I.J.5
-
21
-
-
1842479017
-
Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas: Correlation of nuclear factor-κB immunoreactivity with disease recurrence
-
Ross JS, Kallakury BV, Sheehan CE, et al. Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas: correlation of nuclear factor-κB immunoreactivity with disease recurrence. Clin Cancer Res 2004;10:2466-72.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 2466-2472
-
-
Ross, J.S.1
Kallakury, B.V.2
Sheehan, C.E.3
-
22
-
-
4344622788
-
Growth and survival mechanisms associated with perineural invasion in prostate cancer
-
Ayala GE, Dai H, Ittmann M, et al. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 2004;64:6082-90.
-
(2004)
Cancer Res
, vol.64
, pp. 6082-6090
-
-
Ayala, G.E.1
Dai, H.2
Ittmann, M.3
-
23
-
-
11144237891
-
Nuclear factor-κB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer
-
Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F. Nuclear factor-κB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 2004;10:8460-4.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8460-8464
-
-
Fradet, V.1
Lessard, L.2
Begin, L.R.3
Karakiewicz, P.4
Masson, A.M.5
Saad, F.6
-
24
-
-
27944434722
-
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse
-
Domingo-Domenech J, Mellado B, Ferrer B, et al. Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer 2005;93:1285-94.
-
(2005)
Br J Cancer
, vol.93
, pp. 1285-1294
-
-
Domingo-Domenech, J.1
Mellado, B.2
Ferrer, B.3
-
25
-
-
0842327809
-
Expression of NF-κB in prostate cancer lymph node metastases
-
Ismail HA, Lessard L, Mes-Masson AM, Saad F. Expression of NF-κB in prostate cancer lymph node metastases. Prostate 2004;58:308-13.
-
(2004)
Prostate
, vol.58
, pp. 308-313
-
-
Ismail, H.A.1
Lessard, L.2
Mes-Masson, A.M.3
Saad, F.4
-
26
-
-
0037613523
-
Judging new markers by their ability to improve predictive accuracy
-
Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003;95:634-5.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 634-635
-
-
Kattan, M.W.1
-
27
-
-
33644792162
-
Validation of 1997 Partin tables' lymph node invasion prediction in men treated with radical prostatectomy in Montreal, Quebec
-
Karakiewicz P, Lattouf JB, Perrotte P, et al. Validation of 1997 Partin tables' lymph node invasion prediction in men treated with radical prostatectomy in Montreal, Quebec. Can J Urol 2005;12:2588-92.
-
(2005)
Can J Urol
, vol.12
, pp. 2588-2592
-
-
Karakiewicz, P.1
Lattouf, J.B.2
Perrotte, P.3
-
28
-
-
0142008439
-
The addition of interleukin-6 soluble receptor and transforming growth factor β1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer
-
Kattan MW, Shariat SF, Andrews B, et al. The addition of interleukin-6 soluble receptor and transforming growth factor β1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. J Clin Oncol 2003;21:3573-9.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3573-3579
-
-
Kattan, M.W.1
Shariat, S.F.2
Andrews, B.3
-
29
-
-
0032550753
-
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
-
Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90:766-71.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 766-771
-
-
Kattan, M.W.1
Eastham, J.A.2
Stapleton, A.M.3
Wheeler, T.M.4
Scardino, P.T.5
-
30
-
-
0032950295
-
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
-
Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499-507.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1499-1507
-
-
Kattan, M.W.1
Wheeler, T.M.2
Scardino, P.T.3
-
31
-
-
0034858126
-
The role of constitutive NF-κB activity in PC-3 human prostate cancer cell invasive behavior
-
Lindholm PF, Bub J, Kaul S, Shidham VB, Kajdacsy-Balla A. The role of constitutive NF-κB activity in PC-3 human prostate cancer cell invasive behavior. Clin Exp Metastasis 2000;18:471-9.
-
(2000)
Clin Exp Metastasis
, vol.18
, pp. 471-479
-
-
Lindholm, P.F.1
Bub, J.2
Kaul, S.3
Shidham, V.B.4
Kajdacsy-Balla, A.5
|